InterCure Ltd.
IRCLF
Get informed when a big investor buys or sells
+ FollowMarket Cap$47.79M
Close$
Share Statistics
| Market cap | $47.79 Million |
|---|---|
| Enterprise Value | $184.34 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | -17.89% |
|---|---|
| Return on Assets | -10.27% |
| Return on Invested Capital | -19.40% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.76 |
| Enterprise Value to EBIT | -1.99 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.99 |
| Debt to Equity | 0.46 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Intercure Ltd
CEO: Alexander Rabinovitch InterCure Ltd. operates as an investment holding company, with interests in the medical cannabis, biomedicine, life sciences, technology, and medical devices fields. It operates through the Investments in Biomed Portfolio Companies segme...